INTENSIFICATION OF TREATMENT WITH VINCA ALKALOID DOES NOT IMPROVE OUTCOMES IN PEDIATRIC PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS* RESULTS FROM THE JPLSG LCH-12 STUDY

被引：0
|
作者：
Morimoto, Akira [1 ]
Shioda, Yoko [2 ]
Kudo, Kazuko [3 ]
Kanegane, Hirokazu [4 ]
Imamura, Toshihiko [5 ]
Koh, Katsuyoshi [6 ]
Kosaka, Yoshiyuki [7 ]
Yuza, Yuki [8 ]
Nakazawa, Atsuko [9 ]
Saito, Akiko [10 ]
Watanabe, Tomoyuki [11 ]
Nakazawa, Yozo [12 ]
机构：
[1] Jichi Med Univ, Dept Pediat, Sch Med, Shimotsuke, Tochigi, Japan
[2] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan
[3] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi, Japan
[4] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Child Hlth & Dev, Tokyo, Japan
[5] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan
[6] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan
[7] Hyogo Prefectural Kobe Childrens Hosp, Dept Hematol Oncol, Kobe, Hyogo, Japan
[8] Tokyo Metropolitan Childrens Med Ctr, Dept Hematol Oncol, Tokyo, Japan
[9] Saitama Childrens Med Ctr, Dept Clin Res, Saitama, Japan
[10] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan
[11] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Hlth & Nutr, Nisshin, Japan
[12] Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S34 / S35
页数：2
相关论文
共 39 条
  • [1] Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study
    Morimoto, Akira
    Shioda, Yoko
    Kudo, Kazuko
    Kanegane, Hirokazu
    Imamura, Toshihiko
    Koh, Katsuyoshi
    Kosaka, Yoshiyuki
    Yuza, Yuki
    Nakazawa, Atsuko
    Saito, Akiko M.
    Watanabe, Tomoyuki
    Nakazawa, Yozo
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (01) : 107 - 118
  • [2] Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study
    Akira Morimoto
    Yoko Shioda
    Kazuko Kudo
    Hirokazu Kanegane
    Toshihiko Imamura
    Katsuyoshi Koh
    Yoshiyuki Kosaka
    Yuki Yuza
    Atsuko Nakazawa
    Akiko M. Saito
    Tomoyuki Watanabe
    Yozo Nakazawa
    [J]. International Journal of Hematology, 2023, 118 : 107 - 118
  • [3] ORGAN DYSFUNCTION IN LANGERHANS CELL HISTIOCYTOSIS (LCH) - TREATMENT RESULTS IN DAL-HX 83 STUDY
    HEITGER, A
    GOBEL, U
    RITTER, J
    GADNER, H
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 432 - 432
  • [4] Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis - Results from the Japan Langerhans cell histiocytosis study group-96 protocol study
    Morimoto, Akira
    Ikushima, Satoshi
    Kinugawa, Naoko
    Ishii, Eiichi
    Kohdera, Urara
    Sako, Masahiro
    Fujimoto, Junichiro
    Bessho, Fumio
    Horibe, Keizo
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    [J]. CANCER, 2006, 107 (03) : 613 - 619
  • [5] 2-chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients
    Stine, KC
    Saylors, RL
    Williams, LL
    Becton, DL
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 29 (04): : 288 - 292
  • [6] Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study
    Cui, Lei
    Wang, Chan-Juan
    Lian, Hong-Yun
    Zhang, Li
    Ma, Hong-Hao
    Wang, Dong
    Chen, Fen-Fen
    Zhang, Qing
    Yang, Ying
    Wei, Ang
    Huang, Xiao-Tong
    Zhu, Ting
    Wang, Tian-You
    Li, Zhi-Gang
    Zhang, Rui
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : 598 - 607
  • [7] Radiotherapy is effective in Langerhans cell histiocytosis (LCH) -: long-term results of a multicenter study in 63 patients
    Micke, O
    Seegenschmiedt, MH
    Olschewski, T
    Bruns, F
    Heyd, R
    Schäfer, U
    Eich, HT
    Willich, N
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S101 - S101
  • [8] DOES EARLY CHEMOTHERAPY INFLUENCE THE NATURAL COURSE OF DISEASE IN LANGERHANS CELL HISTIOCYTOSIS (LCH) - RESULTS OF THE DAL-HX 83 STUDY
    GADNER, H
    HEITGER, A
    GATTERER, I
    GOBEL, U
    JANKASCHAUB, GE
    KUHL, J
    RITTER, J
    [J]. BLUT, 1988, 57 (04): : 222 - 222
  • [9] Greek National Registry Results of Pediatric Patients With Langerhans Cell Histiocytosis (LCH) Spanning Two Decades. A Hellenic Society of Pediatric Hematology-Oncology Study (HESPHO)
    Papadakis, V.
    Servitzoglou, M.
    Tourkantoni, N.
    Chatzipantelis, M.
    Papakonstantinou, E.
    Pelagiadis, I.
    Dana, E.
    Doganis, D.
    Tsipou, H.
    Petrikkos, L.
    Routzouni, K.
    Tragiannidis, A.
    Kosmidis, E.
    Stiakaki, E.
    Polychronopoulou, S.
    Kattamis, A.
    Baka, M.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S326 - S326
  • [10] Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study
    Akira Morimoto
    Yoko Shioda
    Toshihiko Imamura
    Kazuko Kudo
    Toshiyuki Kitoh
    Hiroshi Kawaguchi
    Hiroaki Goto
    Yoshiyuki Kosaka
    Yukiko Tsunematsu
    Shinsaku Imashuku
    [J]. International Journal of Hematology, 2018, 108 : 192 - 198
1234